Precision medicine can be defined as a "developing approach to disease treatment and prevention that takes individual diversity in genes, environment, and lifestyle under consideration for every person." Doctors and researchers are going to be able to anticipate more correctly whether treatment and prevention methods for a specific disease will work in which groups of people using this approach. It differs from a one-size-fits-all strategy, during which disease treatment and prevention techniques are designed for the standard person with little regard for individual differences.
Pharmaceuticals that are characterized as high-cost, high-complexity, and/or high-touch are referred to as specialty medications or specialty drugs. Biologics are "drugs created from living cells" that are injectable or infused (although some are oral treatments) to treat difficult or rare chronic medical conditions like cancer. Drugs are classified as specialty when their cost is much greater than that of non-specialty drugs. Any drug with a negotiated price of $670 per month or more is considered a specialty drug by Medicare and is placed in a specialty tier with a higher patient cost sharing requirement.
Title : Resveratrol derivatives a new tool for osteogenic induction in the treatment of peri implantitis
Barbara De Filippis, University “G. d’Annunzio, Italy
Title : Non-coding RNAs in the cardiovascular disorders linked to Chronic Kidney Disease
Laurent Metzinger, University of Picardie Jules Verne, France
Title : Drugs as an environmental problem chromatographic and computational studies of drugs partition between soil and water
Anna Weronika Sobanska, Medical University of Lodz, Poland
Title : miR-29b inhibition in triple negative cells target apoptosis and autophagy related mechanisms
Cornelia Braicu, Iuliu Haţieganu University of Medicine and Pharmacy, Romania
Title : Synthesis and in vitro study of antiproliferative heterocyclic scaffolds
Hitendra M Patel, Sardar Patel University, India
Title : Mucoadhesive microcapsule: A novel approach for controlling & sustained drug delivery!
Subas Chandra Dinda, Teerthanker Mahaveer University, India